Wall Street smiles on first US autologous aesthetic cell therapy approval
23 June 2011
Donna Young
Please Login to read the full article.
23 June 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- InSite to raise $22M to advance PhIII pipeline including combo product for lid margin disease
- AMAG, Allos to merge – but will it really bring sales synergies for Feraheme, Folotyn?
- NeoStem raises $16.5M as it continues to shift its focus to cell therapy
- Acura investors euphoric over US FDA OK of oxycodone painkiller
